SMAD5 and chronic myelogenous leukemia, BCR-ABL1 positive: Also, to further demonstrate that the increase in cell proliferation rate observed upon miR-155 overexpression in CD34+ CML cells resulted specifically from SMAD5 down-regulation, we transfected CD34+ CML cells with siRNA against SMAD5.